Eli Lilly

Pfizer

AbbVie

Merck

Bristol-Myers

Abbott Labs

Johnson & Johnson

Amgen

Tarsus Pharmaceuticals

Gilead Sciences

Invesco Dynamic Pharmaceuticals ETF

PJP tracks an index of US pharmaceutical companies selected and weighted based on various factors using a quantitative methodology.

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on 06/23/2005.

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

Bullish on pharmaceuticals and health care due to relative momentum and preference for "need" sectors over cyclical ones. The Invesco Pharmaceuticals ETF provides exposure to select pharmaceutical stocks with specific criteria for selection and a dynamic approach. The fund holds 24 stocks, primarily in pharmaceuticals, biotech, and healthcare equipment, with heavyweights like AbbVie, Regeneron, Eli Lilly, and Abbott Laboratories.

PJP: A Dynamic Pharma Fund

First Trust Nasdaq Pharmaceuticals ETF 

iShares U.S. Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

SPDR S&P Pharmaceuticals ETF

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.

Pharma ETFs in Focus Post Solid Q2 Earnings

Fidelity MSCI Consumer Staples ETF

Tema Obesity & Cardiometabolic ETF

iShares U.S. Aerospace & Defense ETF

iShares U.S. Healthcare ETF

iShares U.S. Consumer Goods ETF

Roundhill GLP-1 & Weight Loss ETF

Invesco Aerospace & Defense ETF

Global X Defense Tech ETF

Amplify Weight Loss Drug & Treatment ETF

Vanguard Consumer Staples ETF

Vanguard Utilities ETF

SPDR S&P Aerospace & Defense ETF

Consumer Staples Select Sector SPDR Fund

Utilities Select Sector SPDR Fund

Health Care Select Sector SPDR Fund

When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.

Disruptive Theme of the Week: Playing Defense

A Look at Pharma ETFs Post Q1 Earnings

Invesco Dynamic Pharmaceuticals ETF is a passively managed fund that tracks the Dynamic Pharmaceutical Intellidex Index. Investing in the pharmaceutical industry is challenging due to the need for specialized knowledge and the industry's underperformance. PJP is overvalued, has lower expected earnings growth, and higher fees compared to its competitors.

PJP: Pharma Investing Is Difficult And This Fund Doesn't Make It Easier

The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs reported solid results, with some beating on earnings or revenues or both.

A Look at Pharma ETFs After Q4 Earnings

Pharma ETFs in Focus Post Q3 Earnings

Healthcare, the second-largest sector allocation in the S&P 500, is often viewed through the lens of defensive and value traits. The latter scenario is being amplified this year, as the S&P 500 Health Care Index is lower by 3.8%.

Where to Find Value Among Pharma Stocks

VanEck Vectors Biotech ETF

iShares Nasdaq Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

Bank of America expects the Gilead Sciences to jump about 30%, as quoted on CNBC.

Time for Gilead Sciences-Heavy ETFs?

Invesco Treasury Collateral ETF

Asian Growth CUBS ETF

Invesco Defensive Equity ETF

Invesco DWA SmallCap Momentum ETF

Invesco S&P MidCap 400 Equal Weight ETF

Strategy Shares Nasdaq 5handl Index ETF

PGIM Global High Yield Fund

iBet Sports Betting & Gaming ETF

NightShares 500 1x/1.5x ETF

Invesco Dynamic Biotechnology & Genome ETF

Invesco Dynamic Food & Beverage ETF

Invesco Dynamic Media ETF

Invesco PureBeta 0-5 Yr US TIPS ETF

Invesco PureBeta MSCI USA ETF

Invesco DWA Momentum ETF

Invesco Dynamic Leisure and Entertainment ETF

Invesco DWA Consumer Cyclicals Momentum ETF

Invesco DWA Financial Momentum ETF

Invesco DWA Emerging Markets Momentum ETF

Invesco DWA Developed Markets Momentum ETF

Invesco Dynamic Building & Construction ETF

Invesco 1-30 Laddered Treasury ETF

Invesco DWA Industrials Momentum Portfolio

Invesco Dynamic Semiconductors ETF

A total of nine funds launched during the week ending Sept. 1, thus a dip after the 17 ETF launches last week but not unusual in the leadup to a holiday weekend.

This Week in ETFs: Invesco Makes Changes to 35 Funds

Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.

Pharma ETFs in Focus Post Q2 Earnings

SPDR S&P 500 ETF Trust

Materials Select Sector SPDR Fund

Communication Services Select Sector SPDR Fund

Financial Select Sector SPDR Fund

SPDR S&P Oil & Gas Exploration & Production ETF

It has been almost a month since the second-quarter earnings season kicked off. These sectors emerged winners so far in this earnings season.

5 Sector ETF Winners Amid Q2 Earnings Season

If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the Invesco Dynamic Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on 06/23/2005.

Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?

55 percent of Invesco Dynamic Pharmaceuticals ETF's investment is in ten giant-capitalized and large-capitalized biopharmaceutical stocks which delivered poor returns over the long run. 18 blockbuster drugs of these ten companies with an annual revenue of at least $100 billion are facing the heat of patent expiration within this decade. These firms are focusing on orphan drugs, revenues of which are highly uncertain, as those rare diseases generally have a limited addressable market.

PJP: Concentrating On Large-Cap Biopharmaceuticals Seems To Be A Bad Strategy

First Trust Morningstar Dividend Leaders Index Fund

Amplify Treatments Testing & Advancements ETF

iShares Core High Dividend ETF

Horizon Kinetics Medical ETF

Moderna

Novavax

The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.

Biotech ETFs in Focus on Covid Vaccines' Fall Rollout

Many pharmaceutical companies have become highly dependent on a small number of drugs, if not one flagship drug. At the same time, the prescription pharmaceutical industry has become complicated, requiring ongoing monitoring and heightened investor awareness.

Want to Invest in Pharmaceutical Stocks but Don't Know How? Try This ETF.

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.

Pharma ETFs Gain Post Q1 Earnings

The Invesco Dynamic Pharmaceuticals ETF (PJP) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

Virtus LifeSci Biotech Clinical Trials ETF

First Trust NYSE Arca Biotechnology Index Fund

iShares U.S. Healthcare Providers ETF

iShares U.S. Medical Devices ETF

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

SPDR S&P Biotech ETF

How SVB's collapse is impacting healthcare startups. Pfizer to buy Seagen for $43B.

The Fall Of SVB: What It Means For Healthcare Startups

Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.

A Look at Pharma ETFs Post Q4 Earnings

Global X Longevity Thematic ETF 

ARK Genomic Revolution Multi-Sector ETF

Virtus LifeSci Biotech Products ETF

BlackRock Future Health ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Global X Telemedicine & Digital Health ETF

Fidelity MSCI Health Care ETF

First Trust Health Care AlphaDEX Fund

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

iShares Genomics Immunology and Healthcare ETF

iShares Global Healthcare ETF

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Novo Nordisk

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Simplify Health Care ETF

Invesco S&P SmallCap Health Care ETF

Invesco DWA Healthcare Momentum ETF

ALPS Medical Breakthroughs ETF

Wisdomtree BioRevolution Fund

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

Subversive Decarbonization ETF

Subversive Food Security ETF

Subversive Mental Health ETF

The debut highlights the lack of funds focused on the area.

Subversive Launches ETF to Focus on Mental Health

Horizon Pharma

Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from the proposed deal.

Amgen to Buy Horizon Therapeutics: ETFs to Bet On

News for Invesco Dynamic Pharmaceuticals ETF ETF (PJP)